Humana Inc. $HUM Stake Increased by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC grew its holdings in Humana Inc. (NYSE:HUM) by 8.6% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,206 shares of the insurance provider’s stock after purchasing an additional 1,844 shares during the period. Mutual of America Capital Management LLC’s holdings in Humana were worth $5,673,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of HUM. Revolve Wealth Partners LLC purchased a new stake in shares of Humana in the fourth quarter valued at $202,000. GAMMA Investing LLC lifted its holdings in shares of Humana by 54.9% in the first quarter. GAMMA Investing LLC now owns 2,952 shares of the insurance provider’s stock valued at $781,000 after purchasing an additional 1,046 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Humana by 144.4% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 15,734 shares of the insurance provider’s stock valued at $4,163,000 after purchasing an additional 9,296 shares in the last quarter. Janney Montgomery Scott LLC purchased a new stake in shares of Humana during the first quarter worth $1,309,000. Finally, Cambridge Investment Research Advisors Inc. raised its holdings in shares of Humana by 3.2% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 4,608 shares of the insurance provider’s stock worth $1,219,000 after acquiring an additional 145 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on HUM. Wells Fargo & Company increased their price objective on Humana from $344.00 to $347.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Royal Bank Of Canada increased their price objective on Humana from $283.00 to $322.00 and gave the stock an “outperform” rating in a report on Thursday, August 21st. Evercore ISI began coverage on Humana in a report on Monday, September 22nd. They set an “in-line” rating and a $295.00 price objective for the company. Piper Sandler cut their price objective on Humana from $288.00 to $272.00 and set a “neutral” rating for the company in a report on Thursday, July 31st. Finally, Morgan Stanley cut their price objective on Humana from $290.00 to $277.00 and set an “equal weight” rating for the company in a report on Thursday, July 31st. Eight analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Humana currently has an average rating of “Hold” and a consensus target price of $297.58.

Humana Price Performance

NYSE HUM opened at $295.20 on Wednesday. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $315.35. The stock’s 50-day moving average is $281.27 and its two-hundred day moving average is $258.60. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The firm has a market cap of $35.50 billion, a P/E ratio of 22.66, a price-to-earnings-growth ratio of 1.66 and a beta of 0.42.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The company had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. During the same quarter last year, the business earned $6.96 earnings per share. Humana’s quarterly revenue was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. On average, analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend is Friday, September 26th. Humana’s dividend payout ratio (DPR) is currently 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.